SEAN ADAIR: Open Payments
NPI 1235485178 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,105 in 153 payments from 21 companies in 2025. Trend: 2023 $1,599 · 2024 $1,859 · 2025 $2,105
Food & beverage: $1,972Education: $133
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $376 |
| ABBVIE INC. | 21 | $282 |
| Almirall LLC | 34 | $251 |
| UCB, Inc. | 19 | $221 |
| E.R. Squibb & Sons, L.L.C. | 14 | $163 |
| Lilly USA, LLC | 9 | $126 |
| Novartis Pharmaceuticals Corporation | 6 | $104 |
| PFIZER INC. | 5 | $87 |
| Organon LLC | 8 | $80 |
| Regeneron Healthcare Solutions, Inc. | 5 | $77 |
Products named: TREMFYA, Seysara, Bimzelx, SKYRIZI, Sotyktu, TALTZ, DUPIXENT, CIBINQO.
Industry payments across NJ — which companies pay providers there.
